Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

577 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of Early Intrapatient Variability of Tacrolimus Concentrations on the Risk of Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation Using High-Dose Post-Transplant Cyclophosphamide.
Marco DN, Salas MQ, Gutiérrez-García G, Monge I, Riu G, Carcelero E, Roma JR, Llobet N, Arcarons J, Suárez-Lledó M, Martínez N, Pedraza A, Domenech A, Rosiñol L, Fernández-Avilés F, Urbano-Ispízua Á, Rovira M, Brunet M, Martínez C. Marco DN, et al. Among authors: rovira m. Pharmaceuticals (Basel). 2022 Dec 9;15(12):1529. doi: 10.3390/ph15121529. Pharmaceuticals (Basel). 2022. PMID: 36558980 Free PMC article.
High-Dose Cyclophosphamide and Tacrolimus as Graft-versus-Host Disease Prophylaxis for Matched and Mismatched Unrelated Donor Transplantation.
Pedraza A, Jorge S, Suárez-Lledó M, Pereira A, Gutiérrez-García G, Fernández-Avilés F, Rosiñol L, Llobet N, Solano T, Urbano-Ispízua Á, Rovira M, Martínez C. Pedraza A, et al. Among authors: rovira m. Transplant Cell Ther. 2021 Jul;27(7):619.e1-619.e8. doi: 10.1016/j.jtct.2021.03.022. Epub 2021 Mar 25. Transplant Cell Ther. 2021. PMID: 33895157 Free article.
Effect of CD34+ Cell Dose on the Outcomes of Allogeneic Stem Cell Transplantation with Post-Transplantation Cyclophosphamide.
Pedraza A, Salas MQ, Rodríguez-Lobato LG, Charry P, Suárez-Lledo M, Martínez-Cibrian N, Doménech A, Solano MT, Arcarons J, de Llobet N, Rosiñol L, Gutiérrez-García G, Avilés FF, Urbano-Ispízua Á, Rovira M, Martínez C. Pedraza A, et al. Among authors: rovira m. Transplant Cell Ther. 2023 Mar;29(3):181.e1-181.e10. doi: 10.1016/j.jtct.2022.12.005. Epub 2022 Dec 14. Transplant Cell Ther. 2023. PMID: 36526259 Free article.
Single Antigen-Mismatched Unrelated Hematopoietic Stem Cell Transplantation Using High-Dose Post-Transplantation Cyclophosphamide Is a Suitable Alternative for Patients Lacking HLA-Matched Donors.
Jorge AS, Suárez-Lledó M, Pereira A, Gutierrez G, Fernández-Avilés F, Rosiñol L, Llobet N, Solano T, Urbano-Ispízua Á, Rovira M, Martínez C. Jorge AS, et al. Among authors: rovira m. Biol Blood Marrow Transplant. 2018 Jun;24(6):1196-1202. doi: 10.1016/j.bbmt.2018.01.021. Epub 2018 Feb 2. Biol Blood Marrow Transplant. 2018. PMID: 29410343 Free article.
Deleterious Effect of Steroids on Cytomegalovirus Infection Rate after Allogeneic Stem Cell Transplantation Depends on Pretransplant Cytomegalovirus Serostatus of Donors and Recipients.
Suárez-Lledó M, Martínez-Cibrián N, Gutiérrez-García G, Dimova-Svetoslavova V, Marcos MA, Martín-Antonio B, Martínez-Trillos A, Villamor N, Rosiñol L, Martínez C, Fernández-Avilés F, García-Vidal C, Urbano-Ispizua Á, Rovira M. Suárez-Lledó M, et al. Among authors: rovira m. Biol Blood Marrow Transplant. 2018 Oct;24(10):2088-2093. doi: 10.1016/j.bbmt.2018.05.001. Epub 2018 May 9. Biol Blood Marrow Transplant. 2018. PMID: 29753162 Free article. Clinical Trial.
Efficacy and safety of one-day offline extracorporeal photopheresis schedule processing one total blood volume for treating patients with graft-versus-host disease.
Cid J, Carbassé G, Suárez-Lledó M, Moreno DF, Martínez C, Gutiérrez-García G, Fernández-Avilés F, Rosiñol L, Giavedoni P, Mascaró JM Jr, Agustí C, Marín P, Rovira M, Urbano-Ispizua Á, Lozano M. Cid J, et al. Among authors: rovira m. Transfusion. 2019 Aug;59(8):2636-2642. doi: 10.1111/trf.15384. Epub 2019 May 28. Transfusion. 2019. PMID: 31135994 Clinical Trial.
Quantitative PCR Is Faster, More Objective, and More Reliable Than Immunohistochemistry for the Diagnosis of Cytomegalovirus Gastrointestinal Disease in Allogeneic Stem Cell Transplantation.
Suárez-Lledó M, Marcos MÁ, Cuatrecasas M, Bombi JA, Fernández-Avilés F, Magnano L, Martínez-Cibrián N, Llobet N, Rosiñol L, Gutiérrez-García G, Jorge S, Martínez C, Rovira M, Urbano-Ispizua Á. Suárez-Lledó M, et al. Among authors: rovira m. Biol Blood Marrow Transplant. 2019 Nov;25(11):2281-2286. doi: 10.1016/j.bbmt.2019.07.016. Epub 2019 Jul 17. Biol Blood Marrow Transplant. 2019. PMID: 31325586 Free article. Clinical Trial.
A reproducible and safe at-home allogeneic haematopoietic cell transplant program: first experience in Central and Southern Europe.
Gutiérrez-García G, Rovira M, Arab N, Gallego C, Sánchez J, Ángeles Álvarez M, Ayora P, Domenech A, Borràs N, Gerardo Rodríguez-Lobato L, Rosiñol L, Marín P, Pedraza A, Martínez-Roca A, Carcelero E, Dolores Herrera M, Teresa Solano M, Ramos C, de Llobet N, Serrahima A, Lozano M, Cid J, Martínez C, Suárez-Lledó M, Urbano-Ispizua Á, Fernández-Avilés F. Gutiérrez-García G, et al. Among authors: rovira m. Bone Marrow Transplant. 2020 May;55(5):965-973. doi: 10.1038/s41409-019-0768-x. Epub 2020 Jan 13. Bone Marrow Transplant. 2020. PMID: 31932656
577 results